We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$15.2B
AUM Growth
-$88.9M
Cap. Flow
-$687M
Cap. Flow %
-4.5%
Top 10 Hldgs %
44.55%
Holding
1,138
New
213
Increased
453
Reduced
272
Closed
195

Sector Composition

Rank Sector Weight
1 Energy 55.03%
2 Financials 7.13%
3 Healthcare 4.31%
4 Consumer Discretionary 2.88%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
176
Amgen
AMGN
$203B
$4.31M 0.03%
20,788
+12,226
+143% +$2.41M
PVG
177
DELISTED
PRETIUM RESOURCES INC.
PVG
$4.27M 0.03%
561,450
-527,233
-48% -$4.33M
ANAB icon
178
AnaptysBio
ANAB
$1.6B
$4.24M 0.03%
42,535
+8,441
+25% +$700K
FSM icon
179
Fortuna Silver Mines
FSM
$2.59B
$4.21M 0.03%
962,772
-293,820
-23% -$1.44M
CG icon
180
Carlyle Group
CG
$16.3B
$4.2M 0.03%
186,175
-37,164
-17% -$874K
FWONA icon
181
Liberty Media Series A
FWONA
$22.3B
$4.09M 0.03%
120,107
-9,851
-8% -$327K
ARNA
182
DELISTED
Arena Pharmaceuticals Inc
ARNA
$4.02M 0.03%
87,326
+16,332
+23% +$662K
AVGO icon
183
Broadcom
AVGO
$1.82T
$4.01M 0.03%
162,690
+101,600
+166% +$2.28M
CDE icon
184
Coeur Mining
CDE
$15.6B
$3.95M 0.03%
741,393
-504,979
-41% -$3.27M
PTCT icon
185
PTC Therapeutics
PTCT
$6.37B
$3.88M 0.03%
82,666
+15,261
+23% +$631K
ONCE
186
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$3.59M 0.02%
65,860
+12,152
+23% +$831K
SBSW icon
187
Sibanye-Stillwater
SBSW
$5.92B
$3.59M 0.02%
1,441,696
-1,652,856
-53% -$3.97M
PCRX icon
188
Pacira BioSciences
PCRX
$1.02B
$3.56M 0.02%
72,484
+13,370
+23% +$578K
HON icon
189
Honeywell
HON
$77.1B
$3.52M 0.02%
23,404
+15,316
+189% +$2.17M
AU icon
190
AngloGold Ashanti
AU
$40.3B
$3.51M 0.02%
408,608
-125,738
-24% -$1.04M
GBT
191
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.5M 0.02%
92,112
+17,396
+23% +$771K
BMY icon
192
Bristol-Myers Squibb
BMY
$127B
$3.41M 0.02%
+54,972
New +$3.26M
ENTA icon
193
Enanta Pharmaceuticals
ENTA
$372M
$3.39M 0.02%
39,684
+6,549
+20% +$656K
KGC icon
194
Kinross Gold
KGC
$28.5B
$3.39M 0.02%
1,254,486
-206,895
-14% -$670K
GOOGL icon
195
Alphabet (Google) Class A
GOOGL
$3.91T
$3.33M 0.02%
55,140
+13,220
+32% +$800K
ATRA icon
196
Atara Biotherapeutics
ATRA
$71.2M
$3.32M 0.02%
3,210
+677
+27% +$662K
SSRM icon
197
SSR Mining
SSRM
$5.57B
$3.23M 0.02%
370,796
-467,998
-56% -$4.42M
TBPH icon
198
Theravance Biopharma
TBPH
$874M
$3.19M 0.02%
97,513
+17,906
+22% +$488K
GS icon
199
Goldman Sachs
GS
$313B
$3.14M 0.02%
13,987
+8,094
+137% +$1.88M
MU icon
200
Micron Technology
MU
$1.04T
$3.1M 0.02%
68,537
+13,306
+24% +$671K

Similar funds

ALPS Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, ALPS Advisors held 1,138 positions worth $15.2B, down 0.58% from $15.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

ALPS Advisors withdrew a net $687M in Q3 2018, closing 195 positions and reducing 272 holdings. Its most notable exit was Williams Partners L.P., an estimated $859M position sold in full.

By sector, the portfolio is most concentrated in Energy at 55% of assets, up from 54% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ALPS Advisors opened a new position in Kirkland Lake Gold Ltd Ordinary worth $19.6M.

  • ALPS Advisors's largest Q3 2018 buy was Kirkland Lake Gold Ltd Ordinary: 1,029,518 shares worth $19.6M.
  • ALPS Advisors added most to Tallgrass Energy, LP Class A Shares in Q3 2018, an estimated $205M increase.
  • ALPS Advisors's biggest Q3 2018 reduction was Energy Transfer Partners, L.P., cutting an estimated $195M.
  • ALPS Advisors fully exited Williams Partners L.P. in Q3 2018, selling an estimated $859M.
  • ALPS Advisors's ten largest holdings make up 45% of its $15.2B portfolio in Q3 2018.
  • ALPS Advisors opened 213 new positions and closed 195 in Q3 2018.
  • ALPS Advisors's portfolio value fell 0.58% quarter-over-quarter to $15.2B.

Based on ALPS Advisors's 13F filing for Q3 2018, filed 25 Oct 2018.